home · filing · 0001493152-25-008794
8-K
filed March 3, 2025, 6:59 PM ET
CIK 0001883788
leadership
confidence high
sentiment negative
materiality 0.55
DIH Holding US director and CMO Patrick Bruno resigns amid policy violations; no severance
DIH HOLDING US, INC.
Dr. Patrick Bruno resigned from board and as CMO of subsidiary Hocoma Medical GmbH effective Feb 25, 2025.
Resignation triggered by violations of company policies; Termination Agreement includes mutual releases and non-disparagement.
Bruno receives salary through resignation date but no bonus for current or prior fiscal year; no severance.
Board reduces size to five members; vacancy not immediately filled.
Termination Agreement supersedes May 2017 employment agreement.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2025-02-25
Filed March 3, 2025, 6:59 PM ET
Dr. Bruno also resigned as Chief Market Officer of the Company’s subsidiary, Hocoma Medical GmbH
Departed
Patrick Bruno
Director
DIH HOLDING US, INC.
Effective 2025-02-25
Filed March 3, 2025, 6:59 PM ET
Effective February 25, 2025, Dr. Patrick Bruno resigned from the Board of Directors of DIH Holding US, Inc.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Patrick Bruno resigned as Chief Market Officer of Hocoma Medical GmbH at DIH HOLDING US, INC..
Action resigned
Role Chief Market Officer of Hocoma Medical GmbH
Exact text from the filing
Dr. Bruno also resigned as Chief Market Officer of the Company’s subsidiary, Hocoma Medical GmbH
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Patrick Bruno resigned as Director at DIH HOLDING US, INC..
Action resigned
Role Director
Exact text from the filing
Effective February 25, 2025, Dr. Patrick Bruno resigned from the Board of Directors of DIH Holding US, Inc.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-25-008794
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.